top of page
Hyperpolarized MRI Agents:
Visualize Cancer Metabolism – As It Happens
EACR 2025 | 16-19 June 2025 | Lisbon, Portugal
Join us at this year’s EACR Congress to discover how NVision Imaging Technologies is transforming the way we see cancer. With our breakthrough hyperpolarized MRI agents, you gain a unique advantage by observing metabolic processes as they occur within living organisms, both in real-time and with spatial resolution.
Unlock Metabolic Insights:
In vivo. Real time. Non-invasive.
Our POLARIS platform turns natural biomolecules into powerful metabolic imaging agents by labeling them with carbon-13 and enhancing their MRI signal up to 100,000-fold. This enables you to:
-
Visualize and quantify metabolic flux in vivo
-
Quantify dynamic pathway activity (i.e. glycolysis and oxidative phosphorylation)
-
Perform non-invasive longitudinal studies in the same subject
-
Improve stratification and subtyping based on metabolic signatures
-
Assess treatment response and therapy resistance within days
Don’t Miss Our Industry Spotlight Talk
“Hyperpolarized MRI Agents: Visualize Cancer Metabolism - As It Happens”
18 June 2025 14:30–15:15 Auditorium VI+VII Dr. Simon Bennett
Learn how NVision Imaging Technologies is revolutionizing cancer research! Our hyperpolarized MRI agents enable you to visualize cancer metabolism - as it happens.
14:30–14:40: Introduction to ¹³C Hyperpolarization
14:40–15:10: Applications for Imaging and Measuring Metabolism In Vivo
.png){kind=small}
Meet NVision at EACR 2025
We’re excited to share our latest results, explore your research goals, and show how NVision can power your discoveries.
Interested to learn more? Join our spotlight talk on 18th June, or join us at our industry booth (Stand 112) for a friendly chat! If you're looking for a more in-depth conversation tailored to your goals, we encourage you to schedule a dedicated meeting.
Book your personalized meeting!
bottom of page